Emo E van Halsema1, Jeanin E van Hooft1, Aaron J Small2, Todd H Baron3, Jesús García-Cano4, Jae Hee Cheon5, Moon Sung Lee6, Se Hwan Kwon7, Stéphanie Mucci-Hennekinne8, Paul Fockens1, Marcel G W Dijkgraaf9, Alessandro Repici10. 1. Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, the Netherlands. 2. Division of Gastroenterology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA. 3. Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. 4. Department of Gastroenterology, Hospital Virgen de la Luz, Cuenca, Spain. 5. Department of Internal Medicine, Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea. 6. Department of Internal Medicine, Soon Chun Hyang University Bucheon Hospital, Bucheon, Korea. 7. Department of Radiology, Kyung Hee University Medical Center, Seoul, Korea. 8. Department of Visceral Surgery, Centre Hospitalier Universitaire d'Angers, Angers, France. 9. Clinical Research Unit, Academic Medical Center, Amsterdam, The Netherlands. 10. Department of Digestive Endoscopy, Istituto Clinico Humanitas, Milan, Italy.
Abstract
BACKGROUND: Recent studies suggest that there is a substantial risk of perforation after colorectal stent placement. OBJECTIVE: To identify risk factors for perforation from colonic stenting. DESIGN: A meta-analysis of 86 studies published between 2005 and 2011. SETTING: Multicenter review. PATIENTS: All patients who underwent colorectal stent placement. INTERVENTION: Colorectal stent placement. MAIN OUTCOME MEASUREMENTS: The occurrence of perforation with subgroup analyses for stent design, stricture etiology, stricture dilation, and concomitant chemotherapy, including the use of bevacizumab. RESULTS: A total of 4086 patients underwent colorectal stent placement; perforation occurred in 207. Meta-analysis revealed an overall perforation rate of 7.4%. Of the 9 most frequently used stent types, the WallFlex, the Comvi, and the Niti-S D-type had a higher perforation rate (>10%). A lower perforation rate (<5%) was found for the Hanarostent and the Niti-S covered stent. Stenting benign strictures was associated with a significantly increased perforation rate of 18.4% compared with 7.5% for malignant strictures. Dilation did not increase the risk of perforation: 8.5% versus 8.5% without dilation. The subgroup of post-stent placement dilation had a significantly increased perforation risk of 20.4%. With a perforation rate of 12.5%, bevacizumab-based therapy was identified as a risk factor for perforation, whereas the risk for chemotherapy without bevacizumab was 7.0% and not increased compared with the group without concomitant therapies during stent therapy (9.0%). LIMITATIONS: Heterogeneity; a considerable proportion of data is unavailable for subgroup analysis. CONCLUSIONS: The perforation rate of colonic stenting is 7.4%. Stent design, benign etiology, and bevacizumab were identified as risk factors for perforation. Intraprocedural stricture dilation and concomitant chemotherapy were not associated with an increased risk of perforation.
BACKGROUND: Recent studies suggest that there is a substantial risk of perforation after colorectal stent placement. OBJECTIVE: To identify risk factors for perforation from colonic stenting. DESIGN: A meta-analysis of 86 studies published between 2005 and 2011. SETTING: Multicenter review. PATIENTS: All patients who underwent colorectal stent placement. INTERVENTION: Colorectal stent placement. MAIN OUTCOME MEASUREMENTS: The occurrence of perforation with subgroup analyses for stent design, stricture etiology, stricture dilation, and concomitant chemotherapy, including the use of bevacizumab. RESULTS: A total of 4086 patients underwent colorectal stent placement; perforation occurred in 207. Meta-analysis revealed an overall perforation rate of 7.4%. Of the 9 most frequently used stent types, the WallFlex, the Comvi, and the Niti-S D-type had a higher perforation rate (>10%). A lower perforation rate (<5%) was found for the Hanarostent and the Niti-S covered stent. Stenting benign strictures was associated with a significantly increased perforation rate of 18.4% compared with 7.5% for malignant strictures. Dilation did not increase the risk of perforation: 8.5% versus 8.5% without dilation. The subgroup of post-stent placement dilation had a significantly increased perforation risk of 20.4%. With a perforation rate of 12.5%, bevacizumab-based therapy was identified as a risk factor for perforation, whereas the risk for chemotherapy without bevacizumab was 7.0% and not increased compared with the group without concomitant therapies during stent therapy (9.0%). LIMITATIONS: Heterogeneity; a considerable proportion of data is unavailable for subgroup analysis. CONCLUSIONS: The perforation rate of colonic stenting is 7.4%. Stent design, benign etiology, and bevacizumab were identified as risk factors for perforation. Intraprocedural stricture dilation and concomitant chemotherapy were not associated with an increased risk of perforation.
Authors: Su Jin Kim; Hyung Wook Kim; Su Bum Park; Dae Hwan Kang; Cheol Woong Choi; Byeong Jun Song; Joung Boom Hong; Dong Jun Kim; Byung Soo Park; Gyung Mo Son Journal: Surg Endosc Date: 2015-02-13 Impact factor: 4.584
Authors: R Manta; F Tremolaterra; A Arezzo; M Verra; G Galloro; L Dioscoridi; F Pugliese; A Zullo; M Mutignani; G Bassotti Journal: Tech Coloproctol Date: 2015-07-11 Impact factor: 3.781
Authors: Minkyu Jung; Min-Hee Ryu; Do Youn Oh; Myounghee Kang; Dae Young Zang; In Gyu Hwang; Keun-Wook Lee; Ki Hyang Kim; Byoung Yong Shim; Eun Kee Song; Sun Jin Sym; Hye Sook Han; Young Lee Park; Jin Soo Kim; Hyun Woo Lee; Moon Hee Lee; Dong-Hoe Koo; Hong Suk Song; Namsu Lee; Sung Hyun Yang; Dae Ro Choi; Young Seon Hong; Kyoung Eun Lee; Chi Hoon Maeng; Jin Ho Baek; Samyong Kim; Yeul Hong Kim; Sun Young Rha; Jae Yong Cho; Yoon-Koo Kang Journal: Gastric Cancer Date: 2018-02-09 Impact factor: 7.370
Authors: Femke J Amelung; Frank Ter Borg; Esther C J Consten; Peter D Siersema; Werner A Draaisma Journal: Surg Endosc Date: 2016-04-12 Impact factor: 4.584